Core Scientific, Inc. (NASDAQ:CORZ – Free Report) – Equities researchers at Roth Capital increased their FY2027 earnings per share (EPS) estimates for shares of Core Scientific in a note issued to investors on Monday, December 16th. Roth Capital analyst D. Aftahi now anticipates that the company will earn $0.95 per share for the year, up from their previous estimate of $0.88. Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Core Scientific’s current full-year earnings is $0.50 per share. Roth Capital also issued estimates for Core Scientific’s FY2028 earnings at $2.49 EPS.
Several other equities research analysts have also weighed in on CORZ. Compass Point upped their target price on shares of Core Scientific from $18.00 to $20.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Needham & Company LLC raised their price objective on shares of Core Scientific from $17.00 to $18.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. Macquarie lifted their target price on shares of Core Scientific from $16.00 to $19.00 and gave the company an “outperform” rating in a research note on Thursday, November 14th. Jefferies Financial Group started coverage on Core Scientific in a research report on Monday, October 28th. They set a “buy” rating and a $19.00 price target on the stock. Finally, Roth Mkm started coverage on Core Scientific in a research report on Friday, November 15th. They issued a “buy” rating and a $25.50 price objective for the company. Thirteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $18.46.
Core Scientific Price Performance
Core Scientific stock opened at $14.45 on Tuesday. The firm has a market capitalization of $4.04 billion and a P/E ratio of -2.67. The stock has a fifty day moving average price of $15.24 and a two-hundred day moving average price of $11.91. Core Scientific has a 52-week low of $2.61 and a 52-week high of $18.63.
Insider Transactions at Core Scientific
In other Core Scientific news, insider Todd M. Duchene sold 25,000 shares of Core Scientific stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $17.10, for a total transaction of $427,500.00. Following the completion of the sale, the insider now owns 1,661,474 shares of the company’s stock, valued at approximately $28,411,205.40. The trade was a 1.48 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Yadin Rozov sold 105,000 shares of the company’s stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $18.11, for a total transaction of $1,901,550.00. Following the sale, the director now owns 345,239 shares of the company’s stock, valued at $6,252,278.29. The trade was a 23.32 % decrease in their position. The disclosure for this sale can be found here. 32.00% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Core Scientific
A number of institutional investors have recently made changes to their positions in CORZ. Rise Advisors LLC boosted its holdings in Core Scientific by 14.3% during the third quarter. Rise Advisors LLC now owns 8,000 shares of the company’s stock worth $95,000 after buying an additional 1,000 shares during the last quarter. Banque Cantonale Vaudoise bought a new position in Core Scientific during the 2nd quarter worth approximately $28,000. Sunbelt Securities Inc. acquired a new position in Core Scientific during the second quarter valued at approximately $33,000. Vontobel Holding Ltd. increased its stake in Core Scientific by 10.4% in the third quarter. Vontobel Holding Ltd. now owns 38,089 shares of the company’s stock valued at $452,000 after purchasing an additional 3,591 shares in the last quarter. Finally, Harvest Portfolios Group Inc. raised its holdings in Core Scientific by 10.1% in the third quarter. Harvest Portfolios Group Inc. now owns 55,881 shares of the company’s stock worth $663,000 after purchasing an additional 5,109 shares during the period.
About Core Scientific
Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.
Featured Articles
- Five stocks we like better than Core Scientific
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- What is a Death Cross in Stocks?
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.